BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 19240987)

  • 1. Cellular quiescence in mammary stem cells and breast tumor stem cells: got testable hypotheses?
    Harmes DC; DiRenzo J
    J Mammary Gland Biol Neoplasia; 2009 Mar; 14(1):19-27. PubMed ID: 19240987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammary stem cells and progenitors: targeting the roots of breast cancer for prevention.
    Tharmapalan P; Mahendralingam M; Berman HK; Khokha R
    EMBO J; 2019 Jul; 38(14):e100852. PubMed ID: 31267556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of epithelial stem/progenitor cells in mammary cancer.
    Bruno RD; Smith GH
    Gene Expr; 2011; 15(3):133-40. PubMed ID: 22268295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delineating the epithelial hierarchy in the mouse mammary gland.
    Asselin-Labat ML; Vaillant F; Shackleton M; Bouras T; Lindeman GJ; Visvader JE
    Cold Spring Harb Symp Quant Biol; 2008; 73():469-78. PubMed ID: 19022771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem Cells and the Differentiation Hierarchy in Mammary Gland Development.
    Fu NY; Nolan E; Lindeman GJ; Visvader JE
    Physiol Rev; 2020 Apr; 100(2):489-523. PubMed ID: 31539305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RUNX2 in mammary gland development and breast cancer.
    Ferrari N; McDonald L; Morris JS; Cameron ER; Blyth K
    J Cell Physiol; 2013 Jun; 228(6):1137-42. PubMed ID: 23169547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ΔNp63 promotes stem cell activity in mammary gland development and basal-like breast cancer by enhancing Fzd7 expression and Wnt signalling.
    Chakrabarti R; Wei Y; Hwang J; Hang X; Andres Blanco M; Choudhury A; Tiede B; Romano RA; DeCoste C; Mercatali L; Ibrahim T; Amadori D; Kannan N; Eaves CJ; Sinha S; Kang Y
    Nat Cell Biol; 2014 Oct; 16(10):1004-15, 1-13. PubMed ID: 25241036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammary gland stem cells and their application in breast cancer.
    Yang X; Wang H; Jiao B
    Oncotarget; 2017 Feb; 8(6):10675-10691. PubMed ID: 27793013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammary development and breast cancer: the role of stem cells.
    Ercan C; van Diest PJ; Vooijs M
    Curr Mol Med; 2011 Jun; 11(4):270-85. PubMed ID: 21506923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cells in normal mammary gland and breast cancer.
    Luo J; Yin X; Ma T; Lu J
    Am J Med Sci; 2010 Apr; 339(4):366-70. PubMed ID: 20224316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancers, mammary stem cells, and cancer stem cells, characteristics, and hypotheses.
    Taurin S; Alkhalifa H
    Neoplasia; 2020 Dec; 22(12):663-678. PubMed ID: 33142233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MTA family of transcriptional metaregulators in mammary gland morphogenesis and breast cancer.
    Singh RR; Kumar R
    J Mammary Gland Biol Neoplasia; 2007 Sep; 12(2-3):115-25. PubMed ID: 17549610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical cell cycle regulation promotes mammary stem cell expansion during mammary development and tumourigenesis.
    Fifield BA; Vusich J; Haberfellner E; Andrechek ER; Porter LA
    Breast Cancer Res; 2024 Jun; 26(1):106. PubMed ID: 38943151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR203 mediates subversion of stem cell properties during mammary epithelial differentiation via repression of ΔNP63α and promotes mesenchymal-to-epithelial transition.
    DeCastro AJ; Dunphy KA; Hutchinson J; Balboni AL; Cherukuri P; Jerry DJ; DiRenzo J
    Cell Death Dis; 2013 Feb; 4(2):e514. PubMed ID: 23449450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal and cancerous mammary stem cells evade interferon-induced constraint through the miR-199a-LCOR axis.
    Celià-Terrassa T; Liu DD; Choudhury A; Hang X; Wei Y; Zamalloa J; Alfaro-Aco R; Chakrabarti R; Jiang YZ; Koh BI; Smith HA; DeCoste C; Li JJ; Shao ZM; Kang Y
    Nat Cell Biol; 2017 Jun; 19(6):711-723. PubMed ID: 28530657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt signaling, stem cells, and the cellular origin of breast cancer.
    Lindvall C; Bu W; Williams BO; Li Y
    Stem Cell Rev; 2007 Jun; 3(2):157-68. PubMed ID: 17873348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conserved and variable: Understanding mammary stem cells across species.
    Rauner G; Ledet MM; Van de Walle GR
    Cytometry A; 2018 Jan; 93(1):125-136. PubMed ID: 28834173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assays for functionally defined normal and malignant mammary stem cells.
    Aalam SMM; Beer PA; Kannan N
    Adv Cancer Res; 2019; 141():129-174. PubMed ID: 30691682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis.
    Visvader JE
    Genes Dev; 2009 Nov; 23(22):2563-77. PubMed ID: 19933147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone regulation of stem and progenitor cells in normal and malignant breast.
    Axlund SD; Sartorius CA
    Mol Cell Endocrinol; 2012 Jun; 357(1-2):71-9. PubMed ID: 21945473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.